Roundtable Discussion: Streamlining CMC & Maintaining Purity During Scale Up of RNAi Payloads & Delivery Systems to Streamline RNAi Therapeutic Production & Maximize Clinical Success
Time: 9:40 am
day: Conference Day Two
Details:
- Employing analytical methods to measure toxicity and purity of manufactured RNA
- Increasing efficiency during manufacturing and scale up
- How different delivery platforms require differing CMC considerations
